Cesarean Section
Conditions
Interventions
Sponsors
Renshou Maternity and Child Health Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1. voluntarily agreed to participate by giving written informed consent 2. aged between 18 and 35 years old (including the cuoff) when consent 3. single birth and mature birth women 4. ASA score I-II 5. voluntarily accept the randomized treament 6. No contraindications to lumbar hemp or epidural anesthesia 7. Consent or ask for postoperative PCEA analgesia pump installation 8. successful anesthetization, no liquids when pumping back the conduit, without additional local anesthetic to the epidural space during the operation 9. Subject must have adequate hematologic and end organ function as indicated by the following laboratory values: Absolute neutrophil count (ANC) = 2*10^9/L Hemoglobin= 90 g/L Platelets= 100*10^9/L Serum total bilirubin=20umol/L ALT=38mmol/l AST=38mmol/l Serum creatinine (Cr) 44-97umol/L Blood urea nitrogen 2.86-8.20mmol/L 10. Coagulation International Normalized Ratio (INR) 0.86-1.30 Prothrombin Time (PT) = 16.00S Activated Partial Thromboplastin Time (aPTT) =45.00S.
Exclusion criteria
Exclusion criteria: 1. Without the basic examinations before the cesarean section ( including but not limited to blood, urine, chemistry test, ECG and ultrasound); 2. unsuccessful anesthetization (including anesthetization failure, single side anesthetization and high plane anesthetization (T4)); 3. Subject changes to general anesthetization during the cesarean section; 4. Subject receives the extra anesthetic or auxiliary analgesics; 5. Subject has the pregnancy-induced hypertension syndrome; 6. Subject has the pregnancy-induced diabetes; 7. Subject is accompanying the serious heart, lung, liver and kidney disease; 8. Subject needs the opioid to treat the chronic pain; 9. Subject has the drug abuse history; 10. Subject has the history of spinal canal anesthesia; 11. Subject has the food or drug allergy history; 12. Subject has the spine malformation; 13. Subject has the trauma surgery history; 14. Subject has the mental disease history; 15. Other conditions that investigators think should be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incision pain;uterine contraction pain;Pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative sedation effections;Recovery of muscle strength of lower limbs;Recovery of gastrointestinal function;Recovery of Bladder function;Usage of the analgesia pump in numbers;Patient satisfaction of analgesia; | — |
Countries
China
Contacts
Public ContactJian Peng
Outcome results
None listed